Célia Dupain

703 total citations
16 papers, 209 citations indexed

About

Célia Dupain is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Célia Dupain has authored 16 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Célia Dupain's work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (5 papers) and Peptidase Inhibition and Analysis (3 papers). Célia Dupain is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (5 papers) and Peptidase Inhibition and Analysis (3 papers). Célia Dupain collaborates with scholars based in France, Italy and United States. Célia Dupain's co-authors include Liliane Massaad-Massade, Giorgia Urbinati, Birgit Geoerger, Grégoire Marret, Maud Kamal, Christophe Le Tourneau, Édith Borcoman, Yannick Boursin, Ivan Bièche and Pierre Khoueiry and has published in prestigious journals such as Cancer Research, Oncogene and Annals of Oncology.

In The Last Decade

Célia Dupain

13 papers receiving 205 citations

Peers

Célia Dupain
Sook Kyung South Korea
Manuel Torres-Diz Spain
Chengcheng Shi China
Dmitri Grebennik United States
Zorka Inić Serbia
Jinyeong Lim South Korea
Helen Pasternack Germany
Nikola Hájková Czechia
Maria Teresa Ionta Italy
Mingkun Zhan China
Sook Kyung South Korea
Célia Dupain
Citations per year, relative to Célia Dupain Célia Dupain (= 1×) peers Sook Kyung

Countries citing papers authored by Célia Dupain

Since Specialization
Citations

This map shows the geographic impact of Célia Dupain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Célia Dupain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Célia Dupain more than expected).

Fields of papers citing papers by Célia Dupain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Célia Dupain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Célia Dupain. The network helps show where Célia Dupain may publish in the future.

Co-authorship network of co-authors of Célia Dupain

This figure shows the co-authorship network connecting the top 25 collaborators of Célia Dupain. A scholar is included among the top collaborators of Célia Dupain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Célia Dupain. Célia Dupain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Marret, Grégoire, Jerzy Klijanienko, Sophie Vacher, et al.. (2025). Internal validation strategy for high dimensional prognosis model: A simulation study and application to transcriptomic in head and neck tumors. Computational and Structural Biotechnology Journal. 27. 3792–3802. 1 indexed citations
2.
Choussy, Olivier, Grégoire Marret, Jerzy Klijanienko, et al.. (2025). A clustering-stratified cross-validation framework for validating omics survival models: application to head and neck cancer. BMC Medical Research Methodology. 25(1). 277–277.
3.
Gabriel, Marc, Panagiotis Papoutsoglou, Charlotte Lecerf, et al.. (2025). Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment. NAR Cancer. 7(4). zcaf036–zcaf036.
4.
Dupain, Célia, Grégoire Marret, Xavier Paolettí, et al.. (2024). Pan‐cancer evaluation of tumor‐infiltrating lymphocytes and programmed cell death protein ligand‐1 in metastatic biopsies and matched primary tumors. The Journal of Pathology. 264(2). 186–196.
5.
Bartoletti, Michele, Ivan Bièche, Giuseppe Curigliano, et al.. (2024). Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance. Molecular Diagnosis & Therapy. 29(1). 91–101. 1 indexed citations
6.
Hilmi, Marc, Maud Kamal, Sophie Vacher, et al.. (2023). Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial. European Journal of Cancer. 183. 152–161. 26 indexed citations
7.
8.
9.
Cyrta, Joanna, Elodie Girard, Sophie Vacher, et al.. (2023). Molecular characterisation of tumours of the lacrimal apparatus. Histopathology. 83(6). 925–935. 2 indexed citations
10.
Dupain, Célia, Grégoire Marret, Xavier Paolettí, et al.. (2022). Abstract 1724: Pancancer evaluation of tumor infiltrating lymphocytes (TILs) and PD-L1 in SHIVA-01 trial patients with different biopsy sites and histological types. Cancer Research. 82(12_Supplement). 1724–1724. 1 indexed citations
11.
Borcoman, Édith, et al.. (2021). HDAC Inhibition to Prime Immune Checkpoint Inhibitors. Cancers. 14(1). 66–66. 47 indexed citations
12.
Marret, Grégoire, Ivan Bièche, Célia Dupain, et al.. (2021). Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT). JCO Precision Oncology. 5(5). 215–226. 22 indexed citations
13.
Dupain, Célia, et al.. (2019). Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progression. Oncogene. 38(47). 7200–7215. 8 indexed citations
14.
Dupain, Célia, et al.. (2018). Discovery of New Fusion Transcripts in a Cohort of Pediatric Solid Cancers at Relapse and Relevance for Personalized Medicine. Molecular Therapy. 27(1). 200–218. 23 indexed citations
15.
Dupain, Célia, et al.. (2017). Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine. Molecular Therapy — Nucleic Acids. 6. 315–326. 45 indexed citations
16.
Dupain, Célia, et al.. (2016). Induction of TTF-1 or PAX-8 expression on proliferation and tumorigenicity in thyroid carcinomas. International Journal of Oncology. 49(3). 1248–1258. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sook Kyung Breakdown of academic impact, for papers by Manuel Torres-Diz Breakdown of academic impact, for papers by Chengcheng Shi Breakdown of academic impact, for papers by Dmitri Grebennik Breakdown of academic impact, for papers by Zorka Inić Breakdown of academic impact, for papers by Jinyeong Lim Breakdown of academic impact, for papers by Helen Pasternack Breakdown of academic impact, for papers by Nikola Hájková Breakdown of academic impact, for papers by Maria Teresa Ionta Breakdown of academic impact, for papers by Mingkun Zhan
Rankless by CCL
2026